Association Between Papillary Thyroid Cancer and Primary Aldosteronism in Individuals With Hypertension - Takeaways - MDSpire

Association Between Papillary Thyroid Cancer and Primary Aldosteronism in Individuals With Hypertension

  • By

  • Ana Alice W Maciel

  • Debora L S Danilovic

  • Ibere C Soares

  • Thais C Freitas

  • Jessica Okubo

  • Gustavo F C Fagundes

  • Felipe Freitas-Castro

  • Lucas S Santana

  • Augusto G Guimaraes

  • Vinicius F Calsavara

  • Felipe L Ledesma

  • Luciana A Castroneves

  • Fernando M A Coelho

  • Victor Srougi

  • Fabio Y Tanno

  • Jose L Chambo

  • Francisco C Carnevale

  • João V Silveira

  • Fernanda M Consolim-Colombo

  • Luiz A Bortolotto

  • Luciana P Brito

  • Maria Candida B V Fragoso

  • Luciano F Drager

  • Celso E Gomez-Sanchez

  • Ana Claudia Latronico

  • Berenice B Mendonca

  • Ana O Hoff

  • Madson Q Almeida

  • September 18, 2024

  • 0 min

Share

  • 1

    Primary aldosteronism (PA) is prevalent in patients with papillary thyroid cancer (PTC) and hypertension, with a prevalence of 29.20% in the PTC group.

  • 2

    The frequency of severe hypertension was significantly lower in the PTC group (23%) compared to matched hypertensive controls (73%; P < .001).

  • 3

    After matching controls by hypertension stage, the prevalence of PA was significantly higher in the PTC group (9.56%; P < .0001).

  • 4

    PTC was independently associated with PA in both unmatched and matched hypertensive individuals, indicating a strong link between the conditions.

  • 5

    The study suggests that screening for PA should be recommended for patients with PTC, regardless of the severity of hypertension.

Original Source(s)

Related Content